StreetInsider.com News Articles

West Declares Quarterly Dividend

Mon, 19 Oct 2026 18:04:00 -0400

EXTON, Pa., Oct. 19, 2026 /PRNewswire/ -- On October 19, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared a fourth-quarter dividend of $0.26 per share on the Company's common stock, an 18% increase over the $0.22 per share paid in the prior quarter. This is the thirty-fourth consecutive annual increase in the Company's dividend. The dividend is payable on November 18,

West Declares Quarterly Dividend

Mon, 19 Oct 2026 18:04:00 -0400

West Pharmaceutical (WST) PT Raised to $420 at TD Cowen

Tue, 13 Oct 2026 09:39:28 -0400

TD Cowen analyst Brendan Smith raised the price target on West Pharmaceutical (NYSE: WST) to $420.00 (from $410.00) while maintaining a rating.

West to Host Third-Quarter 2026 Conference Call

Thu, 08 Oct 2026 06:00:00 -0400

EXTON, Pa., Oct. 8, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 29, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.

West to Host Third-Quarter 2026 Conference Call

Thu, 08 Oct 2026 06:00:00 -0400

West Pharmaceutical (WST) PT Raised to $440 at Barclays

Wed, 07 Oct 2026 03:52:55 -0400

Barclays analyst Luke Sergott raised the price target on West Pharmaceutical (NYSE: WST) to $440.00 (from $400.00) while maintaining a Overweight rating.

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

Mon, 05 Oct 2026 06:00:00 -0400

EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in Milan, Italy, where it will highlight its leadership and expertise in addressing industry challenges.

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

Mon, 05 Oct 2026 06:00:00 -0400

Form 4 WEST PHARMACEUTICAL SERV For: Sep 30 Filed by: HAUGEN JANET BRUTSCHEA

Fri, 02 Oct 2026 13:11:00 -0400

si-local-file:///var/storage/secattach/20261002/27140810.html

Morgan Stanley Upgrades West Pharmaceutical (WST) to Overweight

Tue, 22 Sep 2026 06:10:10 -0400

Morgan Stanley analyst Kallum Titchmarsh upgraded West Pharmaceutical (NYSE: WST) from Equalweight to Overweight with a price target of $400.00 (from $365.00).

For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.

Shares of West Pharmaceutical closed at $361.78 yesterday.

Form 4 WEST PHARMACEUTICAL SERV For: Sep 11 Filed by: Favorite Annette F

Tue, 15 Sep 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260915/27065372.html

Form 4 WEST PHARMACEUTICAL SERV For: Sep 08 Filed by: Favorite Annette F

Thu, 10 Sep 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260910/27049564.html

Form 4 WEST PHARMACEUTICAL SERV For: Sep 08 Filed by: Lagarde Michel

Thu, 10 Sep 2026 15:40:00 -0400

si-local-file:///var/storage/secattach/20260910/27048173.html

Form 3 WEST PHARMACEUTICAL SERV For: Aug 31 Filed by: Lagarde Michel

Thu, 10 Sep 2026 15:34:00 -0400

si-local-file:///var/storage/secattach/20260910/27048141.html

UBS Assumes West Pharmaceutical (WST) at Buy

Wed, 09 Sep 2026 06:08:27 -0400

UBS analyst Douglas Schenkel assumes coverage on West Pharmaceutical (NYSE: WST) with a Buy rating and a price target of $415.00.

For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.

Shares of West Pharmaceutical closed at $337.75 yesterday.

West to Participate in Upcoming Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:

West to Participate in Upcoming Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

West to Participate in Upcoming Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

West to Participate in Upcoming Investor Conferences

Wed, 26 Aug 2026 16:00:00 -0400

Form 4 WEST PHARMACEUTICAL SERV For: Aug 11 Filed by: McMahon Robert W.

Wed, 12 Aug 2026 14:57:00 -0400

si-local-file:///var/storage/secattach/20260812/26912145.html

Form 4 WEST PHARMACEUTICAL SERV For: Aug 11 Filed by: McMahon Robert W.

Wed, 12 Aug 2026 14:57:00 -0400

si-local-file:///var/storage/secattach/20260812/26912145.html

Form SCHEDULE 13G WEST PHARMACEUTICAL SERV Filed by: FMR LLC

Thu, 06 Aug 2026 10:44:00 -0400

si-local-file:///var/storage/secattach/20260806/26881441.html

Form SCHEDULE 13G WEST PHARMACEUTICAL SERV Filed by: FMR LLC

Thu, 06 Aug 2026 10:44:00 -0400

si-local-file:///var/storage/secattach/20260806/26881441.html

West Pharmaceutical (WST) PT Raised to $420 at Deutsche Bank

Fri, 24 Jul 2026 07:24:19 -0400

Deutsche Bank analyst Justin Bowers raised the price target on West Pharmaceutical (NYSE: WST) to $420.00 (from $405.00) while maintaining a Buy rating.

Form 10-Q WEST PHARMACEUTICAL SERV For: Jun 30

Thu, 23 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260723/26808322.html